Supplements Industry FAQ

Healthcare payments are catching up with the rest of finance, faster than most people in the industry realise. The market is on track to grow from $23 billion in 2025 to over $60 billion by 2030, a compound annual growth rate above 22%. AI is moving from pilot to production. Real-time payment rails are becoming an expectation. Patients are using ChatGPT to make sense of bills before they ever pick up a phone. The future of healthcare payments is not a distant prospect, it is the next two years.

Vellis Team

Automate your expense tracking with our advanced tools. Categorize your expenditures

Product categories and compliance

1. Which supplement categories does Vellis support?

Vellis supports a broad range of supplement business models, subject to individual underwriting, product review and applicable regulatory requirements. This may include mainstream vitamins and minerals, sports nutrition products, wellness-focused supplements, specialty formulations and other eligible categories. Approval depends on factors such as the product catalogue, ingredients, claims, sales model, fulfilment setup, target markets and processing history. As an authorized provider, Vellis reviews each business on its own merits rather than assuming that every supplement operator presents the same level of risk.

2. Can Vellis process payments for weight loss supplements?

Vellis can assess eligible businesses selling weight loss supplements, but approval is not automatic. These products can receive closer processor scrutiny because of ingredient profiles, advertising language, subscription models and customer expectations. Vellis reviews the complete setup, including the catalogue, product pages, marketing claims, billing structure, fulfilment practices and target markets. The focus is on whether the business can meet processor and regulatory requirements without making unsupported product claims. Vellis acts as an authorized provider and evaluates each application individually before recommending a suitable processing structure.

3. Can Vellis process payments for nootropic and cognitive enhancement supplements?

Vellis can review businesses offering nootropic and cognitive enhancement supplements where the products, claims and operating model meet applicable requirements. This category often requires careful assessment because marketing language can move beyond permitted product descriptions if it implies medical or therapeutic outcomes. Vellis reviews ingredients, product positioning, website content, recurring billing practices and geographic markets before determining whether the business is suitable for processing. Operators can learn more about the sector-specific approach on the Supplements industry page.

4. How does Vellis handle emerging or novel supplement compounds?

Emerging or novel compounds are assessed case by case. Vellis does not rely only on a product category label because processor risk can change depending on the ingredient, formulation, marketing language, market availability and regulatory status in the countries being served. During onboarding, Vellis may request product lists, ingredient information, supplier documentation, website examples and details of how the products are promoted. As an authorized provider, Vellis uses this information to determine whether a suitable processing route is available and what additional controls or documentation may be required.

How does Vellis handle emerging or novel supplement compounds?

5. How does Vellis assess supplement businesses that have been declined by other processors?

A previous decline does not automatically prevent a supplement business from being considered. Vellis reviews why the application may have been rejected and whether the underlying issue can be addressed. This may include product category concerns, unsupported marketing claims, unclear fulfilment practices, high chargeback ratios, subscription transparency, incomplete documentation or market restrictions. Vellis also considers processing history and relevant screening information, including the MATCH list and OFAC checks where applicable. The goal is to understand the full risk profile before deciding whether an eligible processing solution can be structured.

Subscription and DTC operations

6. How does Vellis support supplement subscription and auto-refill billing?

Vellis can support eligible supplement businesses using subscription, membership or auto-refill billing models. The setup is reviewed for clear customer consent, transparent billing terms, accessible cancellation procedures and accurate descriptions of renewal frequency. These details matter because recurring billing can create disputes when customers do not understand when or why they are charged. Vellis works with operators to align the payment setup with their commercial model while meeting processor requirements. The result is a billing structure designed to support recurring revenue without relying on unclear checkout flows or hidden renewal terms.

7. Can Vellis handle high-volume DTC supplement e-commerce processing?

Vellis can assess high-volume direct-to-consumer supplement businesses and structure processing based on transaction volume, average order value, sales channels, chargeback history, fulfilment capacity and geographic reach. Higher volumes require more than simple payment acceptance because sudden changes in traffic or order patterns can trigger additional processor review. Vellis evaluates the operating model and helps align processing capacity with expected demand. For a broader view of how Vellis supports supplement merchants, visit the Supplements industry page.

8. How does Vellis manage failed subscription renewals to reduce involuntary churn?

Failed renewals can happen for many reasons, including expired cards, insufficient funds, issuer declines or outdated payment details. Vellis can support payment setups that use appropriate retry logic, account updater capabilities where available and clear customer communication to improve recovery rates. The objective is to reduce avoidable subscription loss while respecting processor rules and customer consent. Retry strategies should not be overly aggressive, and merchants should monitor decline reasons to identify recurring patterns. A well-managed renewal process can help supplement operators protect recurring revenue without creating unnecessary disputes.

9. How does Vellis handle chargebacks on supplement subscriptions?

Vellis helps supplement operators understand the payment and operational factors that influence chargeback risk. For subscription models, common areas of attention include unclear renewal terms, difficult cancellation processes, delayed fulfilment, customer service gaps and billing descriptors that customers do not recognise. Vellis may review dispute history, chargeback ratios and recurring billing practices during onboarding and ongoing account management. Operators should maintain clear records of customer consent, order fulfilment, refund handling and communication. Strong documentation does not eliminate disputes, but it can make the overall payment programme easier to manage.

10. Can Vellis support marketing-driven volume spikes without triggering processor reviews?

Vellis can help eligible supplement merchants prepare for planned traffic and sales increases, but no provider can guarantee that a processor will never review unusual activity. Large promotional campaigns, influencer launches or seasonal offers can create transaction patterns that differ sharply from historical behaviour. Vellis encourages operators to share forecasts, campaign timing, expected volume changes and fulfilment capacity in advance. This gives the processing setup a clearer operational context and can reduce avoidable surprises. Transparent planning is especially important when transaction volume, average order value or geographic mix changes quickly.

International and multi-market operations

11. Can we sell supplements internationally through Vellis?

Vellis can support eligible international supplement businesses where the products, marketing, payment flows and target markets meet applicable requirements. International sales add additional considerations, including local product rules, payment method preferences, currency presentation, shipping practices and country-specific restrictions. Vellis assesses the business model and intended markets before determining what processing structure may be suitable. Operators planning cross-border growth can review the broader sector approach on the Supplements industry page. Approval remains subject to underwriting and the requirements that apply to each market and processing partner.

12. How does Vellis handle multi-currency checkout for international supplement customers?

Vellis can support multi-currency payment structures for eligible supplement merchants operating across multiple markets. The available setup depends on the acquiring arrangement, supported currencies, settlement preferences and customer locations. Multi-currency checkout can help present prices in a format that is familiar to international customers, while the merchant still needs to understand settlement, conversion and reconciliation implications. Vellis reviews these requirements as part of the broader payment architecture. The focus is on creating a practical cross-border setup rather than promising fixed or predictable foreign exchange outcomes.

13. Can Vellis support supplement operators managing multiple brand portfolios?

Yes, Vellis can assess supplement groups that operate several brands, stores or product lines. Multi-brand structures require clear visibility into which legal entity owns each brand, how products differ, where transactions originate and how fulfilment and customer service are managed. Vellis may review each brand separately even when they sit within the same corporate group, because risk can vary by catalogue, marketing claims and customer profile. A well-structured portfolio setup can also simplify reporting, reconciliation and operational oversight while keeping individual merchant activity easier to understand.

14. How does Vellis handle cross-border supplement shipping and payment considerations?

Cross-border supplement sales involve more than accepting an international card. Operators need to consider whether the products can be sold and shipped into each destination, how duties and delivery expectations are communicated, and whether returns or refunds can be handled efficiently. Payment risk can increase when shipping times are long or customers are unclear about where an order is fulfilled. Vellis reviews these operational factors alongside transaction flows because fulfilment and payment performance are closely connected. Merchants remain responsible for meeting the legal and regulatory requirements that apply to the products they sell.

15. Can Vellis support supplement operators expanding into new geographic markets?

Vellis can help eligible supplement operators plan payment infrastructure for geographic expansion. The review typically covers target countries, expected volumes, currencies, payment methods, product eligibility, fulfilment arrangements and the merchant’s existing processing history. Expansion should be planned before launch because a setup that works in one market may not be appropriate in another. Vellis can assess how the payment structure needs to change as the business grows. More information on sector-specific support is available on the Supplements industry page.

Product claims and marketing

16. How does Vellis review supplement marketing claims during onboarding?

Marketing claims are an important part of supplement underwriting because processors may assess not only what a product contains, but also how it is presented to customers. Vellis reviews product pages, landing pages, advertising language and other customer-facing materials for statements that may create regulatory or processor concerns. Particular attention is given to claims that imply diagnosis, treatment, prevention or guaranteed outcomes. Vellis does not make medical judgments about a compound. The purpose of the review is to identify payment-risk issues and determine whether the merchant’s marketing is compatible with the available processing options.

17. What kinds of product claims most commonly trigger processor reviews?

Claims that suggest a supplement can diagnose, treat, cure or prevent a disease can attract significant processor scrutiny. Reviews may also be triggered by guaranteed results, highly specific outcome promises, before-and-after messaging that implies certainty, or statements that go beyond the documented positioning of the product. Risk can also increase when advertising and product pages use inconsistent claims. Supplement merchants should keep marketing language accurate, supportable and aligned across channels. Vellis reviews these factors from a payment acceptance perspective and does not endorse medical or therapeutic claims about any product or ingredient.

18. How can we structure our marketing pages to reduce processor scrutiny?

Supplement marketing pages should make the commercial offer easy to understand. Product descriptions, pricing, delivery terms, refund policies and subscription conditions should be visible and consistent with the checkout experience. Avoid exaggerated or unsupported claims, and do not use page elements that could mislead customers about expected outcomes. It is also useful to keep company details, customer service information and cancellation instructions easy to find. A clear page structure helps processors understand what is being sold and how customers are treated, which can make underwriting and ongoing account reviews more straightforward.

19. Does Vellis have specific guidance on landing page and product page compliance?

Vellis can provide payment-focused guidance on the website elements that processors commonly review during underwriting. This may include product descriptions, pricing, recurring billing disclosures, refund and cancellation policies, contact information, fulfilment terms and the consistency of marketing claims across landing pages and product pages. The exact requirements depend on the catalogue and target markets. Vellis does not provide medical or legal approval of product claims. For additional sector context, see the Supplements industry page.

20. How does Vellis handle changes to our marketing claims after onboarding?

Material changes to product positioning or marketing claims should be reviewed before they create a mismatch between the approved business profile and the live website. Vellis encourages supplement merchants to communicate significant changes, especially when launching new product categories, new ingredients, new landing pages or stronger promotional claims. Depending on the change, additional documentation or processor review may be required. Ongoing transparency helps keep the processing relationship aligned with the merchant’s actual activity. Vellis can assess the payment implications of those changes as an authorized provider, but it does not validate medical or therapeutic claims.

Start Your Application

Related Articles